Imexpharm

Imexpharm Revenue per Share

The Revenue per Share of Imexpharm (IMP.VN) as of Oct 26, 2026 is 15,850.28 VND. In the previous year, Revenue per Share was 14,318.13 VND — a change of 10.70% (higher).

Revenue per Share

15,850.28VND

YoY

10.70%

Last updated:

Revenue per Share of Imexpharm is 2025 15,850.28 VND. Revenue per Share of Imexpharm was 2024 14,318.13 VND. It decreases by 10.70% higher compared to the previous year.

The Imexpharm Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2020
20,539.82 VND
Jan 1, 2021
18,997.55 VND
Jan 1, 2022
24,653.78 VND
Jan 1, 2023
28,484.35 VND
Jan 1, 2024
14,318.13 VND
Jan 1, 2025
15,850.28 VND
Jan 1, 2026 (e)
18,863.16 VND
Jan 1, 2027 (e)
21,298.39 VND
The Imexpharm Revenue per Share history
YEARRevenue per ShareYoY
est21,298.39VND+12.91%
est18,863.16VND+19.01%
15,850.28VND+10.70%
14,318.13VND-49.73%
28,484.35VND+15.54%
24,653.78VND+29.77%
18,997.55VND-7.51%
20,539.82VND-4.52%
21,512.90VND+16.61%
18,448.84VND-1.59%
18,746.84VND-8.91%
20,580.38VND+6.55%
19,315.54VND-28.37%
26,964.82VND+5.77%
25,494.42VND-3.40%
26,391.03VND+8.78%
24,261.41VND-7.91%
26,344.65VND+15.74%
22,761.24VND+17.48%
19,373.93VND-1.33%
19,634.87VND-10.31%
21,891.92VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Revenue per Share of Imexpharm is 15,850.28 VND in 2025.

Revenue per Share of Imexpharm changed from 14,318.13 VND to 15,850.28 VND, representing a 10.70% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Imexpharm

All Key Metrics — Imexpharm